EMCDDA Home
  • EN
Search

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (vi) New inpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates17.644.764.370.463.856.342.631.93542299
Cocaine4.58.08.28.19.010.18.92.9553130
Stimulants13.419.411.37.47.05.76.93.6105163
Hypnotics and sedatives2.31.93.23.910.120.331.750.0334134
Hallucinogens0.10.30.30.70.30.60.00.02212
Volatile substances6.23.00.90.40.90.60.00.018815
Cannabis 54.621.710.38.07.05.15.90.71565192
Other substances 1.30.91.51.02.01.34.010.9101142
Total1113321515966903451581011387356987

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY,HU, NL, AT, PL, RO, SK, FI, SE, UK, HR, TR 

 Last data available from Poland refer to 2008.                     

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 29 June 2011